Medline Inc. Class A Common Stock (MDLN)

Medline Inc. Class A Common Stock (MDLN) Healthcare & Pipeline Overview

Medline Inc. is a global manufacturer and distributor of medical supplies, operating through Medline Brand and Supply Chain Solutions. The company provides a comprehensive portfolio of medical products and supply chain optimization services to hospitals, surgery centers, physician offices, and other healthcare facilities, competing with companies like ResMed Inc. and Avantor, Inc.

What Is the Investment Thesis for MDLN?

Medline Inc. presents a notable research candidate due to its established market position and comprehensive product offerings. With a market capitalization of $36.31B and a P/E ratio of 31.3, the company demonstrates financial stability. A key value driver is its integrated business model, encompassing both manufacturing and supply chain solutions, which allows for greater control over costs and service delivery. Growth catalysts include the expansion of its product lines and penetration into new geographic markets. However, potential risks include increasing competition in the medical supplies industry and fluctuations in raw material costs. The company's beta of 1.98 suggests higher volatility compared to the market.

Based on FMP financials and quantitative analysis

MDLN Key Highlights

• Medline Inc. operates with a profit margin of 4.1%, reflecting its ability to generate earnings relative to revenue.
• The company's gross margin of 24.6% indicates the profitability of its products and services before operating expenses.
• Medline Inc. serves a diverse range of healthcare providers, including hospitals, surgery centers, physician offices, and nursing homes.
• The company's two segments, Medline Brand and Supply Chain Solutions, provide a comprehensive suite of products and services.
• Medline Inc. was founded in 1966 and has since grown into a major player in the medical supplies industry.

Who Are MDLN's Competitors?

MDLN is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are MDLN's Key Strengths?

• Comprehensive product portfolio
• Integrated supply chain solutions
• Established customer relationships
• Strong market presence

What Are MDLN's Weaknesses?

• Lower profit margin compared to some competitors
• Dependence on third-party suppliers for certain products
• Exposure to fluctuations in raw material costs
• High beta indicating higher volatility

What Could Drive MDLN Stock Higher?

• Expansion of product lines in surgical solutions and front line care.
• Penetration into new geographic markets, particularly in emerging economies.
• Launch of innovative medical products addressing unmet clinical needs (within the next 1-2 years).
• Strategic acquisitions to expand product portfolio and market reach.
• Enhancement of supply chain solutions through technology and data analytics.

What Are the Key Risks for MDLN?

• Rich valuation — a P/E of 31.3 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.
• Insider selling — insiders were net sellers of roughly $3.4B recently.
• Increasing competition from established players and new entrants in the medical supplies industry.
• Regulatory changes impacting medical device approvals and reimbursement policies.
• Economic downturn affecting healthcare spending and demand for medical supplies.
• Fluctuations in raw material costs impacting profitability.
• Disruptions in the global supply chain affecting product availability and delivery.

What Are the Growth Opportunities for MDLN?

• Expansion of Surgical Solutions: Medline can capitalize on the growing demand for advanced surgical solutions by expanding its product portfolio and entering new surgical specialties. The global surgical instruments market is projected to reach $17.4 billion by 2027. By investing in research and development and strategic acquisitions, Medline can enhance its competitive position and capture a larger share of this market. This expansion can be realized within the next 2-3 years.
• Penetration into Emerging Markets: Medline has the opportunity to expand its presence in emerging markets, where healthcare infrastructure is rapidly developing. These markets offer significant growth potential due to increasing healthcare expenditure and unmet medical needs. By establishing strategic partnerships and tailoring its product offerings to local market requirements, Medline can successfully penetrate these markets and drive revenue growth. This expansion can begin immediately and continue over the next 5 years.
• Enhancement of Supply Chain Solutions: Medline can further enhance its supply chain solutions by leveraging technology and data analytics to optimize inventory management, reduce costs, and improve service delivery. The global supply chain management market is projected to reach $27 billion by 2028. By investing in advanced supply chain technologies and expanding its service offerings, Medline can strengthen its competitive advantage and attract new customers. This enhancement can be implemented within the next 1-2 years.
• Development of Innovative Products: Medline can drive growth by developing innovative medical products that address unmet clinical needs and improve patient outcomes. By investing in research and development and collaborating with healthcare professionals, Medline can create differentiated products that command premium pricing and capture market share. The timeline for this growth opportunity depends on the specific product development cycles, but initial results can be expected within 3-5 years.
• Strategic Acquisitions: Medline can pursue strategic acquisitions to expand its product portfolio, enter new markets, and gain access to new technologies. By carefully selecting acquisition targets and integrating them effectively, Medline can accelerate its growth and enhance its competitive position. The timeline for this growth opportunity is ongoing, as Medline continuously evaluates potential acquisition targets.

What Opportunities Does MDLN Have?

• Expansion into emerging markets
• Development of innovative medical products
• Strategic acquisitions to expand product portfolio
• Leveraging technology to enhance supply chain efficiency

What Threats Does MDLN Face?

• Increasing competition in the medical supplies industry
• Regulatory changes impacting medical device approvals
• Economic downturn affecting healthcare spending
• Disruptions in the global supply chain

What Are MDLN's Competitive Advantages?

• Integrated Business Model: Medline's combination of manufacturing and supply chain solutions provides a competitive advantage.
• Extensive Product Portfolio: The company offers a wide range of medical products, catering to diverse customer needs.
• Established Customer Relationships: Medline has built long-term relationships with healthcare providers.
• Supply Chain Expertise: The company's supply chain optimization services enhance customer value and loyalty.

What Does MDLN Do?

Founded in 1966 and headquartered in Northfield, Illinois, Medline Inc. has grown into a major player in the medical supplies industry. The company operates through two primary segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment focuses on the procurement and manufacturing of medical products across three key categories: surgical solutions, front line care, and laboratory and diagnostics. Surgical solutions include surgical procedure trays, drapes, gowns, and surgical instruments. Front line care encompasses products for patient-facing needs such as wound care, gloves, and infection control. The laboratory and diagnostics category offers point of care testing, analyzers, and diagnostic consumables. The Supply Chain Solutions segment provides logistics and supply chain optimization services, including consulting, warehouse management, and inventory rationalization. Medline serves a diverse range of healthcare providers, including hospitals, surgery centers, physician offices, post-acute facilities, and nursing homes, both domestically and internationally. Medline's integrated approach, from manufacturing to supply chain management, allows it to offer comprehensive solutions to its customers, differentiating it from competitors that may focus on specific product categories or services.

What Products and Services Does MDLN Offer?

• Manufactures and distributes medical supplies.
• Provides products to hospitals, surgery centers, and physician offices.
• Offers surgical solutions, including surgical trays and instruments.
• Supplies front line care products like wound care and gloves.
• Provides laboratory and diagnostic products, including analyzers and consumables.
• Offers supply chain optimization services to healthcare providers.
• Distributes third-party products from national brands.

How Does MDLN Make Money?

• Manufacturing and selling Medline-branded medical products.
• Distributing third-party medical products.
• Providing supply chain optimization services to healthcare providers.
• Generating revenue through product sales and service fees.

What Industry Does MDLN Operate In?

Medline Inc. operates in the medical instruments and supplies industry, a sector characterized by steady growth driven by an aging population, increasing healthcare expenditure, and technological advancements. The industry is competitive, with key players like ResMed Inc. and Avantor, Inc. vying for market share. Medline's integrated business model, encompassing both manufacturing and supply chain solutions, positions it favorably in this landscape. The global medical devices market is projected to reach $600 billion by 2026, indicating substantial growth opportunities for companies like Medline.

Who Are MDLN's Key Customers?

• Hospitals
• Surgery Centers
• Physician Offices
• Post-Acute Facilities
• Nursing Homes

Net sellingInsider Activity

Over the past six months, Medline Inc. Class A Common Stock insiders filed 30 SEC Form 4 transactions — 26 sales and 4 purchases. On net that is roughly 129.5M shares disposed (about $3.4B), a signal worth weighing alongside the fundamentals.

ROE 7%Key Financial Metrics

Return on equity for Medline Inc. Class A Common Stock stands at 6.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.5%, showing how much profit it generates from its asset base. MDLN trades at a trailing price-to-earnings ratio of 31.33, above the Healthcare sector average of ~23x. Its free cash flow yield is 4.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 4.41 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.9%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 6/9Financial Health

Medline Inc. Class A Common Stock's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.28 places it in the grey zone, a middle ground that warrants monitoring.

FY2026 estForward Outlook

Wall Street analysts project Medline Inc. Class A Common Stock revenue of about $31.08B for fiscal 2026, with EPS near $1.51. The estimate reflects 19 contributing analysts.

MDLN Valuation & Market Position

With a $36.31B market cap, Medline Inc. Class A Common Stock sits in the large-cap segment of the market. Relative to its peer group, MDLN's quantitative score of 72/100 is roughly in line with the peer average of 69/100.

MDLN Financials

MDLN Latest News

MDLN Analyst Consensus

MDLN MoonshotScore

Latest Medline Inc. Class A Common Stock Analysis

What Investors Ask About Medline Inc. Class A Common Stock (MDLN) — Healthcare

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources